Yoshiyuki Suehara

8PUBLICATIONS
22CO-AUTHORS
Molecular targetsAllergyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 27, 2026
Differences Among Genomic Profiling Tests for Bone and Soft-Tissue Sarcomas in a Universal Health Insurance System.

|Apr 05, 2023
Two-year crizotinib monotherapy induced durable complete response of pediatric ALK-positive inflammatory myofibroblastic tumor.

Akira Kaino, Hidetaka Niizuma, Saori Katayama

|Aug 13, 2021
iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma.

Midori Ishii, Jun Ando, Satoshi Yamazaki

|Jun 17, 2020
Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.

Kei Sano, Yoshiyuki Suehara, Taketo Okubo

|Jul 10, 2019
Protein Expression Profiles Corresponding to Histological Changes with Denosumab Treatment in Giant Cell Tumors of Bone.

Yoshiyuki Suehara, Taketo Okubo, Taisei Kurihara

|Jun 09, 2019
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.

Yoshiyuki Suehara, Deepu Alex, Anita Bowman

Pageof 2

Frequent Collaborators

1 joint publications

Hajime Orita

1 joint publications

Tomoaki Ito

1 joint publications

Tomoyuki Kushida

1 joint publications

Anita Bowman